ArticleBlood research2023

Ibrutinib combined with gemcitabine-vinorelbine for primary refractory non-Hodgkin lymphoma.

Muruvvet Seda Aydin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.